Purchases and Sales Made in Q3 2023 in Cerevel Therapeutics Holdings, Inc. (CERE)
This table provides information about the institutional ownership of Cerevel Therapeutics Holdings, Inc. (CERE) during Q3 2023. The information is specifically focused on institutions that hold shares of Cerevel Therapeutics Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-208K- 39.09% |
$4.22M - $6.65M
|
324K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-318K- 40.04% |
$6.45M - $10.2M
|
477K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-900K- 98.82% |
$18.2M - $28.7M
|
10.8K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-956K- 97.17% |
$19.4M - $30.5M
|
27.9K
$0
|